F₄-neuroprostanes mediate neurological severity in Rett syndrome.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Clinica chimica acta; international journal of clinical chemistry

• Publication date

  2011-07-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.cca.2011.04.016PMID 21530498
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genome-wide expression studies in autism spectrum disorder, Rett syndrome, and Down syndrome.

  2012cited by this paper
• Rett syndrome with and without detected MECP2 mutations: an attempt to redefine phenotypes.

  2011cited by this paper
• Effects of eicosapentaenoic acid on asymmetric dimethylarginine in patients in the chronic phase of cerebral infarction: a preliminary study.

  2011cited by this paper
• Evolutionary Aspects of Diet: The Omega-6/Omega-3 Ratio and the Brain

  2011cited by this paper
• Increased levels of 4HNE-protein plasma adducts in Rett syndrome.

  2011cited by this paper
• Rett syndrome: Revised diagnostic criteria and nomenclature

  2010cited by this paper
• Oxidative damage in Parkinson disease: Measurement using accurate biomarkers.

  2010cited by this paper
• CDKL5 is a brain MeCP2 target gene regulated by DNA methylation.

  2010cited by this paper
• Docosahexaenoic Acid Therapy of Experimental Ischemic Stroke

  2010cited by this paper
• Free iron, total F2‐isoprostanes and total F4‐neuroprostanes in a model of neonatal hypoxic–ischemic encephalopathy: neuroprotective effect of melatonin

  2009cited by this paper
• Systemic Inflammation and the Risk of Alzheimer's Disease and Dementia: A Prospective Population-Based Study

  2009cited by this paper
• On the track of DNA methylation: an interview with Adrian Bird by Jane Gitschier.

  2009cited by this paper
• Diagnostic criteria for the Zappella variant of Rett syndrome (the preserved speech variant).

  2009cited by this paper
• Systemic oxidative stress in classic Rett syndrome.

  2009cited by this paper
• Autism spectrum disorders in genetic syndromes: implications for diagnosis, intervention and understanding the wider autism spectrum disorder population.

  2009cited by this paper
• Plasticity and injury in the developing brain.

  2009cited by this paper
• Understanding Omega-3 Polyunsaturated Fatty Acids

  2009cited by this paper
• On the Track of DNA Methylation: An Interview with Adrian Bird

  2009cited by this paper
• Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice

  2009cited by this paper
• Investigating genotype–phenotype relationships in Rett syndrome using an international data set

  2008cited by this paper
• Mecp2-Null Mice Provide New Neuronal Targets for Rett Syndrome

  2008cited by this paper
• Specific mutations in Methyl-CpG-Binding Protein 2 confer different severity in Rett syndrome

  2008cited by this paper
• Treatment with desipramine improves breathing and survival in a mouse model for Rett syndrome

  2007cited by this paper
• The story of Rett syndrome: from clinic to neurobiology.

  2007cited by this paper
• Italian Rett database and biobank

  2007cited by this paper
• Brain-Derived Neurotrophic Factor Expression and Respiratory Function Improve after Ampakine Treatment in a Mouse Model of Rett Syndrome

  2007cited by this paper
• Reversal of Neurological Defects in a Mouse Model of Rett Syndrome

  2007cited by this paper
• Insights into oxidative stress: the isoprostanes.

  2007cited by this paper
• Secretion of brain‐derived neurotrophic factor from PC12 cells in response to oxidative stress requires autocrine dopamine signaling

  2006cited by this paper
• Correlation between clinical severity in patients with Rett syndrome with a p.R168X or p.T158M MECP2 mutation, and the direction and degree of skewing of X-chromosome inactivation

  2006cited by this paper
• Anti-Inflammatory Actions of Neuroprotectin D1/Protectin D1 and Its Natural Stereoisomers: Assignments of Dihydroxy-Containing Docosatrienes1

  2006cited by this paper
• Differential regulation of c-jun and CREB by acrolein and 4-hydroxynonenal.

  2006cited by this paper
• Nomenclature systems for the neuroprostanes and for the neurofurans.

  2005cited by this paper
• CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndrome.

  2005cited by this paper
• Iron release, superoxide production and binding of autologous IgG to band 3 dimers in newborn and adult erythrocytes exposed to hypoxia and hypoxia-reoxygenation.

  2004cited by this paper
• RettBASE: The IRSA MECP2 variation database—a new mutation database in evolution

  2003cited by this paper
• Effects of MECP2 mutation type, location and X‐inactivation in modulating Rett syndrome phenotype

  2003cited by this paper
• Patients with the R133C mutation: is their phenotype different from patients with Rett syndrome with other mutations?

  2003cited by this paper
• Mutations and polymorphisms in the human methyl CpG‐binding protein MECP2

  2003cited by this paper
• Peripheral F2‐isoprostanes and F4‐neuroprostanes are not increased in Alzheimer's disease

  2002cited by this paper
• Site-specific cross-linking of human and bovine hemoglobins differentially alters oxygen binding and redox side reactions producing rhombic heme and heme degradation.

  2002cited by this paper
• Clinical manifestations and stages of Rett syndrome.

  2002cited by this paper
• Oxidative stress in Rett syndrome.

  2001cited by this paper
• Four siblings with Hallervorden-Spatz disease.

  2001cited by this paper
• Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location.

  2000cited by this paper
• Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes

  2000cited by this paper
• Rett syndrome: analysis of MECP2 and clinical characterization of 31 patients.

  2000cited by this paper
• Studies on mitochondrial pathogenesis of Rett syndrome: ultrastructural data from skin and muscle biopsies and mutational analysis at mtDNA nucleotides 10463 and 2835.

  1999cited by this paper
• Formation of Isoprostane-like Compounds (Neuroprostanes) in Vivo from Docosahexaenoic Acid*

  1998cited by this paper
• Production of superoxide from hemoglobin-bound oxygen under hypoxic conditions.

  1996cited by this paper
• Isolation, physical mapping, and Northern analysis of the X-linked human gene encoding methyl CpG-binding protein, MECP2

  1996cited by this paper
• Fatty acid composition of brain phospholipids in aging and in Alzheimer’s disease

  1991cited by this paper
• A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.

  1990cited by this paper
• Edinburgh Research Explorer Gene Expression Analysis Exposes Mitochondrial Abnormalities in a Mouse Model of Rett Syndrome

  year unknowncited by this paper

• MITOCHONDRIAL REDOX IMBALANCE AND CoQ10 DEFICIENCY IN RETT SYNDROME: INSIGHTS FROM PATIENT-DERIVED FIBROBLASTS.

  2025cites this paper
• MeCP2 at the crossroads of hypoxia, oxidative stress, and gene regulation in Rett syndrome

  2025cites this paper
• Beyond Neuroprostanes: Total Synthesis and Epilipidomic Studies of a Novel Cyclopentenone Metabolite of Docosahexaenoic Acid

  2025cites this paper
• Diet and Nutrients in Rare Neurological Disorders: Biological, Biochemical, and Pathophysiological Evidence

  2024cites this paper
• Ability of a Polyphenol-Rich Nutraceutical to Reduce Central Nervous System Lipid Peroxidation by Analysis of Oxylipins in Urine: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

  2023cites this paper
• Blood–Brain Barrier Integrity Is Perturbed in a Mecp2-Null Mouse Model of Rett Syndrome

  2023cites this paper
• Oral Feeding of an Antioxidant Cocktail as a Therapeutic Strategy in a Mouse Model of Rett Syndrome: Merits and Limitations of Long-Term Treatment

  2022cites this paper
• Isoprostanoid Plasma Levels Are Relevant to Cerebral Adrenoleukodystrophy Disease

  2022cites this paper
• The constitutive activation of TLR4-IRAK1- NFκB axis is involved in the early NLRP3 inflammasome response in peripheral blood mononuclear cells of Rett syndrome patients.

  2022cites this paper
• Sex disparate gut microbiome and metabolome perturbations precede disease progression in a mouse model of Rett syndrome

  2021cites this paper
• Transcriptomic and Epigenomic Landscape in Rett Syndrome

  2021cites this paper
• F4-Neuroprostanes: A Role in Sperm Capacitation

  2021cites this paper
• Circulating 4-F4t-Neuroprostane and 10-F4t-Neuroprostane Are Related to MECP2 Gene Mutation and Natural History in Rett Syndrome

  2021cites this paper
• Cyclopentenone Prostaglandins: Biologically Active Lipid Mediators Targeting Inflammation

  2021cites this paper
• Moving forward with isoprostanes, neuroprostanes and phytoprostanes: where are we now?

  2020cites this paper
• 13-HODE, 9-HODE and ALOX15 as potential players in Rett syndrome OxInflammation.

  2019cites this paper
• The complexity of Rett syndrome models: Primary fibroblasts as a disease-in-a-dish reliable approach

  2019cites this paper
• The molecular determinant of IGF-1(Mecasermin)action in Rett Syndrome Patients

  2018cites this paper
• Key issues in Rett syndrome: emotional, behavioural and autonomic dysregulation (EBAD) - a target for clinical trials

  2018cites this paper
• Relevance of 4‐F4t‐neuroprostane and 10‐F4t‐neuroprostane to neurological diseases

  2018influential citation
• Isoprostanoids in Clinical and Experimental Neurological Disease Models

  2018cites this paper
• Insight into the contribution of isoprostanoids to the health effects of omega 3 PUFAs.

  2017cites this paper
• 4-hydroxynonenal protein adducts: Key mediator in Rett syndrome oxinflammation.

  2017cites this paper
• Melatonin and hydroxytyrosol protect against oxidative stress related to the central nervous system after the ingestion of three types of wine by healthy volunteers.

  2017cites this paper
• MECP2 Duplication Syndrome: Evidence of Enhanced Oxidative Stress. A Comparison with Rett Syndrome

  2016cites this paper
• Rett Syndrome: Crossing the Threshold to Clinical Translation

  2016cites this paper
• Increased non-protein bound iron in Down syndrome: contribution to lipid peroxidation and cognitive decline

  2016cites this paper
• Antiepileptic drugs affect lipid oxidative markers- neuroprostanes and F2-dihomo-isoprostanes- in patients with epilepsy: differences among first-, second-, and third-generation drugs by UHPLC-QqQ-MS/MS

  2016cites this paper
• OxInflammation in Rett syndrome.

  2016cites this paper
• Rett Syndrome: Crossing the Threshold to Clinical

  2016cites this paper
• Syddansk Universitet MECP 2 Duplication Syndrome Evidence of Enhanced Oxidative Stress . A Comparison with Rett Syndrome

  2016cites this paper
• Non-enzymatic cyclic oxygenated metabolites of omega-3 polyunsaturated fatty acid: Bioactive drugs?

  2016cites this paper
• Blood oxidative stress and metallothionein expression in Rett syndrome: Probing for markers

  2016cites this paper
• Proteomic analysis of 4-hydroxynonenal and nitrotyrosine modified proteins in RTT fibroblasts.

  2016cites this paper
• Non-enzymatic cyclic oxygenated metabolites of adrenic, docosahexaenoic, eicosapentaenoic and α-linolenic acids; bioactivities and potential use as biomarkers.

  2015influential citation
• Oxidative stress: a hallmark of Rett syndrome

  2015cites this paper
• Unresolved issues in the analysis of F2-isoprostanes, F4-neuroprostanes, isofurans, neurofurans, and F2-dihomo-isoprostanes in body fluids and tissue using gas chromatography/negative-ion chemical-ionization mass spectrometry

  2015cites this paper
• Dihomo-isoprostanes-nonenzymatic metabolites of AdA-are higher in epileptic patients compared to healthy individuals by a new ultrahigh pressure liquid chromatography-triple quadrupole-tandem mass spectrometry method.

  2015cites this paper
• Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome.

  2015influential citation
• Cytokine Dysregulation in MECP2- and CDKL5-Related Rett Syndrome: Relationships with Aberrant Redox Homeostasis, Inflammation, and ω-3 PUFAs

  2015cites this paper
• The isoprostanes--25 years later.

  2015cites this paper
• Impaired enzymatic defensive activity, mitochondrial dysfunction and proteasome activation are involved in RTT cell oxidative damage.

  2015cites this paper
• Oxygenated metabolites of n-3 polyunsaturated fatty acids as potential oxidative stress biomarkers: total synthesis of 8-F3t-IsoP, 10-F4t-NeuroP and [D4]-10-F4t-NeuroP.

  2014cites this paper
• Redox Imbalance and Morphological Changes in Skin Fibroblasts in Typical Rett Syndrome

  2014cites this paper
• [Oxidative stress and Rett syndrome].

  2014cites this paper
• The role of lipid peroxidation in neurological disorders

  2014cites this paper
• Oxidative brain damage in Mecp2-mutant murine models of Rett syndrome

  2014cites this paper
• Inflammatory Lung Disease in Rett Syndrome

  2014cites this paper
• Pathology of perinatal brain damage: background and oxidative stress markers

  2014cites this paper
• Beta-Actin Deficiency with Oxidative Posttranslational Modifications in Rett Syndrome Erythrocytes: Insights into an Altered Cytoskeletal Organization

  2014cites this paper
• Effects of ω-3 PUFAs Supplementation on Myocardial Function and Oxidative Stress Markers in Typical Rett Syndrome

  2014cites this paper
• Non-enzymatic lipid oxidation products in biological systems: assessment of the metabolites from polyunsaturated fatty acids.

  2014cites this paper
• Safety assessment of docosahexaenoic acid in X-linked retinitis pigmentosa: the 4-year DHAX trial.

  2014cites this paper
• Altered erythrocyte membrane fatty acid profile in typical Rett syndrome: effects of omega-3 polyunsaturated fatty acid supplementation.

  2014cites this paper
• Unregulated Lipid Peroxidation in Neurological Dysfunction

  2014cites this paper
• 4HNE protein adducts in autistic spectrum disorders: Rett syndrome and autism

  2014cites this paper
• Mitochondrial dysfunction in skeletal muscle of a mouse model of Rett Syndrome ( RTT ) : Implications for the disease phenotype .

  2014cites this paper
• Mitochondrial dysfunction in the skeletal muscle of a mouse model of Rett syndrome (RTT): implications for the disease phenotype.

  2014cites this paper
• Fatty Acids and Autism Spectrum Disorders: The Rett Syndrome Conundrum

  2013cites this paper
• Non-protein-bound iron and 4-hydroxynonenal protein adducts in classic autism.

  2013cites this paper
• Isoprostanes and 4-Hydroxy-2-nonenal: Markers or Mediators of Disease? Focus on Rett Syndrome as a Model of Autism Spectrum Disorder

  2013cites this paper
• Revealing the Complexity of a Monogenic Disease: Rett Syndrome Exome Sequencing

  2013influential citation
• A Plasma Proteomic Approach in Rett Syndrome: Classical versus Preserved Speech Variant

  2013cites this paper
• Erythrocyte Shape Abnormalities, Membrane Oxidative Damage, and β-Actin Alterations: An Unrecognized Triad in Classical Autism

  2013cites this paper
• Isoprostanes and neuroprostanes: total synthesis, biological activity and biomarkers of oxidative stress in humans.

  2013cites this paper
• F(2)-Dihomo-isoprostanes and brain white matter damage in stage 1 Rett syndrome.

  2013cites this paper
• Effects of ω-3 Polyunsaturated Fatty Acids on Plasma Proteome in Rett Syndrome

  2013cites this paper
• Total Synthesis of Isoprostanes Derived from Adrenic Acid and EPA

  2012cites this paper
• Morphological changes and oxidative damage in Rett Syndrome erythrocytes.

  2012cites this paper
• Relationship between lipid peroxidation or carcinoembryonic antigen and risk factors for non-communicable diseases in women at midlife and beyond.

  2012cites this paper
• The role of oxidative stress in Rett syndrome: an overview

  2012cites this paper
• Di-(2-ethylhexyl) phthalate and autism spectrum disorders

  2012cites this paper
• Partial rescue of Rett syndrome by ω-3 polyunsaturated fatty acids (PUFAs) oil

  2012cites this paper
• Non conventional synthetic strategies of stapled peptides : modulation of secondary structures to optimise biological recognition

  2012cites this paper
• Oxidative stress in Rett syndrome: Natural history, genotype, and variants

  2011cites this paper
• F2-dihomo-isoprostanes as potential early biomarkers of lipid oxidative damage in Rett syndrome

  2011cites this paper
• A Survey on Rheological Properties of Fruit Jams

  2010cites this paper